6 §Ó §à§Õ§ß§à§Þ  

§¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§à§Ó SARS-CoV-2, MP, RSV, ADV §Ú §Ô§â§Ú§á§á§Ñ A/B

§°§á§Ú§ã§Ñ§ß§Ú§Ö §á§â§à§Õ§å§Ü§ä§Ñ

§¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§à§Ó «6 §Ó 1» §á§â§Ö§Õ§ã§ä§Ñ§Ó§Ý§ñ§Ö§ä §ã§à§Ò§à§Û §Ü§à§Þ§á§Ý§Ö§Ü§ã§ß§í§Û §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§é§Ö§ã§Ü§Ú§Û §Ú§ß§ã§ä§â§å§Þ§Ö§ß§ä, §á§â§Ö§Õ§ß§Ñ§Ù§ß§Ñ§é§Ö§ß§ß§í§Û §Õ§Ý§ñ §à§á§ä§Ú§Þ§Ú§Ù§Ñ§è§Ú§Ú §Ó§í§ñ§Ó§Ý§Ö§ß§Ú§ñ §â§Ñ§Ù§Ý§Ú§é§ß§í§ç §â§Ö§ã§á§Ú§â§Ñ§ä§à§â§ß§í§ç §á§Ñ§ä§à§Ô§Ö§ß§à§Ó, §Ó§Ü§Ý§ð§é§Ñ§ñ SARS-CoV-2, Mycoplasma pneumoniae (MP), §â§Ö§ã§á§Ú§â§Ñ§ä§à§â§ß§à-§ã§Ú§ß§è§Ú§ä§Ú§Ñ§Ý§î§ß§í§Û §Ó§Ú§â§å§ã (RSV), §Ñ§Õ§Ö§ß§à§Ó§Ú§â§å§ã (ADV) §Ú §Ô§â§Ú§á§á. §¡/§¢.§¿§ä§à§ä §Þ§å§Ý§î§ä§Ú§á§Ý§Ö§Ü§ã§ß§í§Û §Ñ§ß§Ñ§Ý§Ú§Ù §à§Ò§Ý§Ö§Ô§é§Ñ§Ö§ä §à§Õ§ß§à§Ó§â§Ö§Þ§Ö§ß§ß§à§Ö §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§Ö, §ã§à§Ü§â§Ñ§ë§Ñ§ñ §Ó§â§Ö§Þ§ñ §Ú §â§Ö§ã§å§â§ã§í, §ß§Ö§à§Ò§ç§à§Õ§Ú§Þ§í§Ö §Õ§Ý§ñ §à§ä§Õ§Ö§Ý§î§ß§í§ç §ä§Ö§ã§ä§à§Ó.§¿§ä§à §à§ã§à§Ò§Ö§ß§ß§à §á§à§Ý§Ö§Ù§ß§à §Ó §Ü§Ý§Ú§ß§Ú§é§Ö§ã§Ü§Ú§ç §å§ã§Ý§à§Ó§Ú§ñ§ç, §Ô§Õ§Ö §Ò§í§ã§ä§â§Ñ§ñ §Õ§Ú§æ§æ§Ö§â§Ö§ß§è§Ú§Ñ§è§Ú§ñ §ï§ä§Ú§ç §á§Ñ§ä§à§Ô§Ö§ß§à§Ó §Ú§Þ§Ö§Ö§ä §â§Ö§ê§Ñ§ð§ë§Ö§Ö §Ù§ß§Ñ§é§Ö§ß§Ú§Ö §Õ§Ý§ñ §Ó§Ö§Õ§Ö§ß§Ú§ñ §á§Ñ§è§Ú§Ö§ß§ä§à§Ó §Ú §á§â§Ú§ß§ñ§ä§Ú§ñ §â§Ö§ê§Ö§ß§Ú§Û §à §Ý§Ö§é§Ö§ß§Ú§Ú.§£§í§ã§à§Ü§Ñ§ñ §é§å§Ó§ã§ä§Ó§Ú§ä§Ö§Ý§î§ß§à§ã§ä§î §Ú §ã§á§Ö§è§Ú§æ§Ú§é§ß§à§ã§ä§î §ß§Ñ§Ò§à§â§Ñ §à§Ò§Ö§ã§á§Ö§é§Ú§Ó§Ñ§ð§ä §ß§Ñ§Õ§Ö§Ø§ß§í§Ö §â§Ö§Ù§å§Ý§î§ä§Ñ§ä§í, §ã§á§à§ã§à§Ò§ã§ä§Ó§å§ñ §Ý§å§é§ê§Ö§Þ§å §Ü§à§ß§ä§â§à§Ý§ð §Ó§ã§á§í§ê§Ö§Ü §Ú §â§Ö§Ñ§Ô§Ú§â§à§Ó§Ñ§ß§Ú§ð §à§Ò§ë§Ö§ã§ä§Ó§Ö§ß§ß§à§Ô§à §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ.§¢§Ý§Ñ§Ô§à§Õ§Ñ§â§ñ §å§á§â§à§ë§Ö§ß§ß§à§Þ§å §â§Ñ§Ò§à§é§Ö§Þ§å §á§â§à§è§Ö§ã§ã§å §ï§ä§à §ï§æ§æ§Ö§Ü§ä§Ú§Ó§ß§à§Ö §â§Ö§ê§Ö§ß§Ú§Ö §Õ§Ý§ñ §Þ§Ö§Õ§Ú§è§Ú§ß§ã§Ü§Ú§ç §â§Ñ§Ò§à§ä§ß§Ú§Ü§à§Ó, §ã§ä§Ñ§Ý§Ü§Ú§Ó§Ñ§ð§ë§Ú§ç§ã§ñ §ã §á§â§à§Ò§Ý§Ö§Þ§Ñ§Þ§Ú §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§Ü§Ú §â§Ö§ã§á§Ú§â§Ñ§ä§à§â§ß§í§ç §Ú§ß§æ§Ö§Ü§è§Ú§Û §ã §á§Ö§â§Ö§Ü§â§í§Ó§Ñ§ð§ë§Ú§Þ§Ú§ã§ñ §ã§Ú§Þ§á§ä§à§Þ§Ñ§Þ§Ú.§¯§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§à§Ó «6-§Ó-1» §á§â§Ö§Õ§ã§ä§Ñ§Ó§Ý§ñ§Ö§ä §ã§à§Ò§à§Û §Ù§ß§Ñ§é§Ú§ä§Ö§Ý§î§ß§í§Û §á§â§à§Ô§â§Ö§ã§ã §Ó §à§Ò§Ý§Ñ§ã§ä§Ú §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§Ü§Ú §Ú§ß§æ§Ö§Ü§è§Ú§à§ß§ß§í§ç §Ù§Ñ§Ò§à§Ý§Ö§Ó§Ñ§ß§Ú§Û, §á§â§Ö§Õ§Ý§Ñ§Ô§Ñ§ñ §Ò§í§ã§ä§â§í§Û, §ä§à§é§ß§í§Û §Ú §ï§Ü§à§ß§à§Þ§Ú§é§Ö§ã§Ü§Ú §ï§æ§æ§Ö§Ü§ä§Ú§Ó§ß§í§Û §Þ§Ö§ä§à§Õ §Ú§Õ§Ö§ß§ä§Ú§æ§Ú§Ü§Ñ§è§Ú§Ú §Ú §Õ§Ú§æ§æ§Ö§â§Ö§ß§è§Ú§Ñ§è§Ú§Ú §à§ã§ß§à§Ó§ß§í§ç §â§Ö§ã§á§Ú§â§Ñ§ä§à§â§ß§í§ç §Ó§Ú§â§å§ã§à§Ó.

§µ§á§Ñ§Ü§à§Ó§Ü§Ñ §á§â§à§Õ§å§Ü§ä§Ñ

§±§â§Ö§Õ§à§ã§ä§Ñ§Ó§Ý§Ö§ß§ß§í§Û §Þ§Ñ§ä§Ö§â§Ú§Ñ§Ý

1. §´§Ö§ã§ä§à§Ó§í§Û §Ü§Ñ§â§ä§â§Ú§Õ§Ø

2. §´§Ñ§Þ§á§à§ß §Õ§Ý§ñ §à§ä§Ò§à§â§Ñ §á§â§à§Ò

3. §¢§å§æ§Ö§â§ß§Ñ§ñ §ä§â§å§Ò§Ü§Ñ §Õ§Ý§ñ §ï§Ü§ã§ä§â§Ñ§Ü§è§Ú§Ú

4. §ª§ß§ã§ä§â§å§Ü§è§Ú§Ú §á§à §Ú§ã§á§à§Ý§î§Ù§à§Ó§Ñ§ß§Ú§ð

§£§Ú§Õ§Ö§à§å§â§à§Ü§Ú

§°§á§Ö§â§Ñ§è§Ú§ñ §Ú §Ú§ß§ä§Ö§â§á§â§Ö§ä§Ñ§è§Ú§ñ §â§Ö§Ù§å§Ý§î§ä§Ñ§ä§à§Ó

§¹§Ñ§ã§ä§à §Ù§Ñ§Õ§Ñ§Ó§Ñ§Ö§Þ§í§Ö §Ó§à§á§â§à§ã§í

§£§à§á§â§à§ã: §¥§Ý§ñ §Ü§à§Ô§à §á§â§Ö§Õ§ß§Ñ§Ù§ß§Ñ§é§Ö§ß §ï§ä§à§ä §Ü§à§Þ§Ò§Ú§ß§Ú§â§à§Ó§Ñ§ß§ß§í§Û §ä§Ö§ã§ä?

§°: §¿§ä§à§ä §Ü§à§Þ§á§Ý§Ö§Ü§ä §á§â§Ö§Õ§ß§Ñ§Ù§ß§Ñ§é§Ö§ß §Õ§Ý§ñ §Ú§ã§á§à§Ý§î§Ù§à§Ó§Ñ§ß§Ú§ñ §Þ§Ö§Õ§Ú§è§Ú§ß§ã§Ü§Ú§Þ§Ú §â§Ñ§Ò§à§ä§ß§Ú§Ü§Ñ§Þ§Ú.

§£: §¹§ä§à §à§Ù§ß§Ñ§é§Ñ§Ö§ä «6 §£ §°§¥§¯§°§®»?

A:6 §Ó §à§Õ§ß§à§Þ §à§Ù§ß§Ñ§é§Ñ§Ö§ä, §é§ä§à §ä§Ö§ã§ä§à§Ó§í§Û §ß§Ñ§Ò§à§â §á§â§Ö§Õ§ã§ä§Ñ§Ó§Ý§ñ§Ö§ä §ã§à§Ò§à§Û §Ü§à§Þ§Ò§Ú§ß§Ú§â§à§Ó§Ñ§ß§ß§í§Û §ä§Ö§ã§ä §Õ§Ý§ñ §Ó§í§ñ§Ó§Ý§Ö§ß§Ú§ñ 6 §Ó§à§Ù§Ò§å§Õ§Ú§ä§Ö§Ý§Ö§Û, §Ñ §Ú§Þ§Ö§ß§ß§à: SARS-CoV-2, Mycoplasma pneumoniae (MP), §â§Ö§ã§á§Ú§â§Ñ§ä§à§â§ß§à-§ã§Ú§ß§è§Ú§ä§Ú§Ñ§Ý§î§ß§à§Ô§à §Ó§Ú§â§å§ã§Ñ (RSV), §Ñ§Õ§Ö§ß§à§Ó§Ú§â§å§ã§Ñ (ADV) §Ú §Ô§â§Ú§á§á§Ñ A/B. .

§£§à§á§â§à§ã: §¬§Ñ§Ü §Ú§ß§ä§Ö§â§á§â§Ö§ä§Ú§â§à§Ó§Ñ§ä§î §â§Ö§Ù§å§Ý§î§ä§Ñ§ä§í?

A: §¦§ã§Ý§Ú §á§à§ñ§Ó§Ý§ñ§ð§ä§ã§ñ §Ü§à§ß§ä§â§à§Ý§î§ß§Ñ§ñ §Ý§Ú§ß§Ú§ñ (C) §Ú §ä§Ö§ã§ä§à§Ó§Ñ§ñ §Ý§Ú§ß§Ú§ñ(§Ú) §Õ§Ý§ñ §Ý§ð§Ò§à§Ô§à §Ú§Ù COV, MP, RSV §Ú§Ý§Ú ADV, FluA §Ú§Ý§Ú FluB, §ä§Ö§ã§ä §á§à§Ý§à§Ø§Ú§ä§Ö§Ý§î§ß§í§Û §ß§Ñ §ã§à§à§ä§Ó§Ö§ä§ã§ä§Ó§å§ð§ë§Ú§Û §á§Ñ§ä§à§Ô§Ö§ß, §ä. §Ö. COV, SARS-CoV-2. ;MP, Mycoplasma Pneumoniae, RSV, §â§Ö§ã§á§Ú§â§Ñ§ä§à§â§ß§à-§ã§Ú§ß§è§Ú§ä§Ú§Ñ§Ý§î§ß§í§Û §Ó§Ú§â§å§ã;§¡§¥§£ ¡ª §Ñ§Õ§Ö§ß§à§Ó§Ú§â§å§ã;§Ô§â§Ú§á§á §¡, §Ô§â§Ú§á§á §¡;§¶§Ý§ð§¢, §Ô§â§Ú§á§á §¢.  

§¦§ã§Ý§Ú §Ü§à§ß§ä§â§à§Ý§î§ß§í§Ö §Ý§Ú§ß§Ú§Ú (C) §Ó§Ú§Õ§ß§í, §ß§à §ß§Ú §à§Õ§ß§Ñ §Ú§Ù §ä§Ö§ã§ä§à§Ó§í§ç §Ý§Ú§ß§Ú§Û (COV, MP, RSV, ADV, FluA, FluB) §ß§Ö §á§à§ñ§Ó§Ý§ñ§Ö§ä§ã§ñ, §ä§Ö§ã§ä §à§ä§â§Ú§è§Ñ§ä§Ö§Ý§î§ß§í§Û.